Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT03967223 |
Title | Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors (IGNYTE-ESO) |
Acronym | IGNYTE-ESO |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | GlaxoSmithKline |
Indications | |
Therapies | |
Age Groups: | senior | child | adult |
Covered Countries | USA | NLD | ITA | GBR | FRA | ESP | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
GSK Investigational Site | Duarte | California | 91010 | United States | Details | |
GSK Investigational Site | Stanford | California | 94305 | United States | Details | |
GSK Investigational Site | Denver | Colorado | 80218 | United States | Details | |
GSK Investigational Site | Jacksonville | Florida | 32224 | United States | Details | |
GSK Investigational Site | Chicago | Illinois | 60637 | United States | Details | |
GSK Investigational Site | Iowa City | Iowa | 52242-1009 | United States | Details | |
GSK Investigational Site | Boston | Massachusetts | 02114 | United States | Details | |
GSK Investigational Site | Ann Arbor | Michigan | 48109 | United States | Details | |
GSK Investigational Site | Minneapolis | Minnesota | 55455 | United States | Details | |
GSK Investigational Site | Rochester | Minnesota | 55905 | United States | Details | |
GSK Investigational Site | Saint Louis | Missouri | 63110 | United States | Details | |
GSK Investigational Site | New York | New York | 10065 | United States | Details | |
GSK Investigational Site | Durham | North Carolina | 27710 | United States | Details | |
GSK Investigational Site | Columbus | Ohio | 43210 | United States | Details | |
GSK Investigational Site | Portland | Oregon | 97239 | United States | Details | |
GSK Investigational Site | Pittsburgh | Pennsylvania | 15232 | United States | Details | |
GSK Investigational Site | Nashville | Tennessee | 37203 | United States | Details | |
GSK Investigational Site | Dallas | Texas | 75390-8565 | United States | Details | |
GSK Investigational Site | Dallas | Texas | 75390-9063 | United States | Details | |
GSK Investigational Site | Salt Lake City | Utah | 84112 | United States | Details | |
GSK Investigational Site | Richmond | Virginia | 23298 | United States | Details | |
GSK Investigational Site | Seattle | Washington | 98109-1024 | United States | Details | |
GSK Investigational Site | Milwaukee | Wisconsin | 53226 | United States | Details | |
GSK Investigational Site | Toronto | Ontario | M5G 2M9 | Canada | Details | |
GSK Investigational Site | Montreal | Quebec | H1T 2M4 | Canada | Details | |
GSK Investigational Site | Lyon cedex 08 | 69373 | France | Details | ||
GSK Investigational Site | Pessac cedex | 33604 | France | Details | ||
GSK Investigational Site | Milano | Lombardia | 20133 | Italy | Details | |
GSK Investigational Site | Rozzano (MI) | Lombardia | 20089 | Italy | Details | |
GSK Investigational Site | Amsterdam | 1066 CX | Netherlands | Details | ||
GSK Investigational Site | Barcelona | 08025 | Spain | Details | ||
GSK Investigational Site | Hospitalet de Llobregat, Barcelona | 08907 | Spain | Details | ||
GSK Investigational Site | Madrid | 28040 | Spain | Details | ||
GSK Investigational Site | Sevilla | 41013 | Spain | Details | ||
GSK Investigational Site | London | SW3 6JJ | United Kingdom | Details | ||
GSK Investigational Site | London | WC1E 6AG | United Kingdom | Details | ||
GSK Investigational Site | Manchester | M20 4BX | United Kingdom | Details |